References
- American College of Rheumatology Subcommittee on Rheuma-toid Arthritis Guidelines. Guidelines for the management of rheu-matoid arthritis: 2002 Update. Arthritis Rheum. 2002;46(2):328–46.
- O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004 350:2591–602.
- Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337:1512–23.
- Roujeau JC, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med 1994;331:1272–85.
- Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Ftheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088–93.
- Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic proper-ties and their clinical implications. J Am Acad Dermatol 2006; 54(2):258–65.
- Elkayam 0, Yaron M, Caspi D. Minocycline-induced autoim-mune syndromes: an overview. Semin Arthritis Rheum 1999;28(6): 392–7.
- Pelletier F, Puzenat E, Blanc D, Faivre B, Humbert P, Aubin F. Minocycline-induced cutaneous polyarteritis nodosa with antineutrophil cytoplasmic antibodies. Eur J Dermatol 2003; 13(4):396–8.
- Schaffer JV, Davidson DM, McNiff JM, Bolognia JL. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous pol-yarteritis nodosa associated with minocycline therapy for acne vul-garis. J Am Acad Dermatol. 2001;44(4198–206.
- Sakai H, Komatsu S, Matsuo S, Ezuka H. Two cases of minocycline-induced vasculitis (in Japanese). Arerugi 2002;51(12): 1153–8.
- Culver B, Itkin A, Pischel K. Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 2005;53(3):468–70.
- Schrodt BJ, Callen JP. Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 1999;103(2): 503–4.